Aigen Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.8M Buy
+12,983
New +$4.27M 0.98% 11
2024
Q1
Sell
-3,717
Closed -$1.75M 762
2023
Q4
$1.75M Sell
3,717
-1,968
-35% -$910K 0.31% 78
2023
Q3
$2.48M Buy
5,685
+3,484
+158% +$1.58M 0.47% 19
2023
Q2
$978K Sell
2,201
-2,612
-54% -$1.2M 0.14% 207
2023
Q1
$2.21M Buy
+4,813
New +$2.29M 0.3% 77
2022
Q4
Sell
-17,444
Closed -$7.92M 600
2022
Q3
$7.92M Buy
17,444
+6,273
+56% +$3M 1.14% 6
2022
Q2
$5.39M Buy
+11,171
New +$5.53M 0.91% 15
2022
Q1
Sell
-2,765
Closed -$1.24M 696
2021
Q4
$1.24M Buy
+2,765
New +$1.16M 0.08% 350
2021
Q2
Sell
-2,729
Closed -$980K 546
2021
Q1
$980K Buy
+2,729
New +$878K 0.13% 181
2020
Q4
Sell
-1,508
Closed -$405K 839
2020
Q3
$405K Sell
1,508
-9,697
-87% -$2.61M 0.05% 448
2020
Q2
$2.95M Buy
11,205
+350
+3% +$93.4K 0.38% 48
2020
Q1
$2.46M Buy
+10,855
New +$2.96M 0.33% 63

Other funds holding ELV

Aigen Investment Management's ELV Position: Q1 2026 in Review

Aigen Investment Management opened a new position in Elevance Health (ELV) in Q1 2026: 12,983 shares worth $3.8M. The stake represents 0.98% of the portfolio and ranks #11 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in ELV as recently as Q4 2023.

Aigen Investment Management first reported a position in ELV in Q1 2020 and has held it in 12 quarters since. The position peaked at $7.92M in Q3 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Aigen Investment Management held 12,983 shares of Elevance Health worth $3.8M as of Q1 2026.
  • Elevance Health was a new Aigen Investment Management position in Q1 2026.
  • Elevance Health made up 0.98% of Aigen Investment Management's portfolio in Q1 2026, its #11 holding.
  • Aigen Investment Management first reported a position in Elevance Health in Q1 2020 and has held it in 12 quarters since.
  • Aigen Investment Management's Elevance Health position peaked at $7.92M in Q3 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.